ArticleNeurochemical research2026
Macrophage Migration Inhibitory Factor Inhibitor ISO-1 Attenuates Anesthesia/Surgery-Induced Cognitive Impairment in Aged Mice: Association with NLRP3 Inflammasome Inhibition.
Article in Neurochemical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Postoperative cognitive dysfunction (POCD) is a serious clinical complication and lacks effective therapeutic approaches. Recent studies demonstrate that targeting macrophage migration inhibitory factor (MIF) offers a novel strategy to cognitive impairment disorders. Here, we aim to investigate whether MIF inhibitor ISO-1 mitigates anesthesia/surgery-evoked cognitive defects via regulating NLRP3 inflammasome. C57BL/6 mice (18-month-old) were selected to establish a POCD model via unilateral nephrectomy under sevoflurane anesthesia. Cognitive and behavioral capabilities were evaluated by fear conditioning, Morris water maze and open field tests. On day 3 postsurgery, MIF levels in the serum and hippocampus were measured through ELISA, immunofluorescence and western blotting. Furthermore, to clarify whether elevated hippocampal MIF following nephrectomy contribute to cognitive decline, ISO-1 (30 mg/kg) was administered intraperitoneally 30 min before and after surgery to reduce hippocampal MIF expression. ELISA and immunofluorescence were used to gauge the levels of hippocampal MIF, IL-6, TNF-α, IL-1β and microglial activation. HE and TUNEL staining were used to assess the morphological alterations and apoptosis in hippocampal neurons. Western blotting was applied to determine the expression of hippocampal MIF, caspase-1, IL-1β, ASC, NLRP3, Bcl-2, Bax and Iba1. We found that surgery-treated mice exhibited pronounced cognitive impairment, accompanied by increased levels of MIF, neuronal apoptosis and neuroinflammation in the hippocampus, as well as the activation of microglia and NLRP3 inflammasome. Inhibition of MIF with ISO-1 can effectively reverse these detrimental changes. Our results reveal that ISO-1 exerts a neuroprotective effect against POCD, which may be associated with the inhibition of NLRP3 inflammasome activation.
Indexed as
Identifiers
42909558What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.